Form 4: IRIDEX CFO Acquires 2,500 Shares
Insider Trading Report (Form 4)
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, acquired 2,500 shares of common stock at $1.38 per share on February 3, 2026.
Summary
- Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), acquired common stock on February 3, 2026.
- The transaction involved the purchase of 2,500 shares of common stock.
- Shares were acquired at a price of $1.38 per share.
- Following this transaction, Mr. Dizon's direct beneficial ownership increased to 115,190 shares.
- The acquisition was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as insider buying, even if pre-planned under a 10b5-1 plan, generally indicates management's belief in the company's value.
Positives
- Chief Financial Officer Romeo R. Dizon acquired 2,500 shares of common stock, signaling confidence in the company's future.
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary purchase.
Industry Context
StockSavvy.ai notes that insider buying, particularly by a Chief Financial Officer, is often interpreted by the market as a positive signal, indicating management's belief in the company's current valuation and future prospects. The use of a Rule 10b5-1 plan suggests the transaction was pre-scheduled and not based on immediate, non-public information.
Related Party Transactions
- Chief Financial Officer Romeo R. Dizon's acquisition of 2,500 shares of IRIDEX Corp common stock.
Stakeholder Impact
- Shareholders may interpret the CFO's share purchase as a positive indicator of management confidence in the company's future performance and valuation.
Key Dates
| Date | Description |
|---|---|
| 02/03/2026 | Acquisition of 2,500 shares of common stock by CFO Romeo R. Dizon. |
Recommendation
holdThe Chief Financial Officer's purchase of shares indicates confidence in the company's future prospects, which is generally a positive signal for investors. However, this single transaction alone does not provide sufficient information to warrant a strong buy or sell recommendation without further fundamental analysis.
Keywords
IRIDEX, IRIX, Insider Trading, Form 4, Stock Purchase, CFO, Romeo Dizon, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.